Amyloid accumulation decreases [18F]-FEOBV uptake in humans (p < 0.005).
“adults with DS displayed lower [ 18 F]‐FEOBV uptake related to higher amyloid accumulation, showing a more significant decline compared to amyloid‐matched controls ( p < 0.005).”
Humansin adults with Down syndrome compared to amyloid-matched controlsbrain
18f-smbt-1 predicts amyloid accumulation in humans (1.20CL/yr vs 0.01CL/yr, p = 0.001).
“In CU A‐ participants with high 18 F‐SMBT‐1 retention, significantly higher Ab accumulation rates were observed compared to low 18 F‐SMBT1 (1.20CL/yr vs 0.01CL/yr, respectively, p = 0.001)”
Humansin cognitively unimpaired amyloid-negative (CU A-) individualsbrainn = 81
In 64 older adults tracked for 2.6 years, lower rapid eye movement sleep was linked to a faster drop in a blood marker of Alzheimer's disease.In 64 older adults tracked for 2.6 years, lower rapid eye movement sleep was linked to a faster drop in a blood marker of Alzheimer's disease.
In an observational study of 1,110 people, living in more deprived areas was associated with lower cognitive scores and more amyloid build-up in unimpaired brains.In an observational study of 1,110 people, living in more deprived areas was associated with lower cognitive scores and more amyloid build-up in unimpaired brains.
A two-year randomised trial in 1,260 older adults at risk of dementia found no clear evidence that starting blood markers altered cognitive benefits.A two-year randomised trial in 1,260 older adults at risk of dementia found no clear evidence that starting blood markers altered cognitive benefits.
In cognitively unimpaired older adults, intermediate amyloid burden showed lower dopamine-transporter deviation scores than amyloid-positive status, with an adjusted…In cognitively unimpaired older adults, intermediate amyloid burden showed lower dopamine-transporter deviation scores than amyloid-positive status, with an adjusted difference of −0.582.